Clinical Trial Update: An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis

View source ↗

Summary

An observational registry evaluating abatacept in patients with Juvenile Idiopathic Arthritis, sponsored by Bristol-Myers Squibb. The study status is ACTIVE_NOT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• ORENCIA (ABATACEPT)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Juvenile Idiopathic Arthritis | Status: ACTIVE_NOT_RECRUITING